Global Epharmacy Market Set To Grow At A Cagr Of 16.7% From 2017-2022

03 August 2017
Pharma

Visiongain’ has launched a new pharma report Global ePharmacy Market Report : US, Canada, Mexico, UK, Germany, Italy, France, Spain, Portugal, India, China, Japan, Australia, GCC, Egypt, South Africa
ePharmacy or online pharmacy or internet pharmacy as it is sometimes called is an internet-based service where vendors can sell various pharmaceutical products both legally or illegally. The current report is an estimation of the legal online pharmacy market. Most pharmaceutical chains are trying to have their online portal to help in establishing a global reach for dispensing drugs. The market however is very sensitive owing to the regulations which though are already established in the developed countries of North America and Europe, is still being framed in emerging countries such as India and China.

The lead analyst of this report commented “ePharmacy has been seen for many years as an upcoming and potentially transformative technology. Factors such as the developing regulations of online pharmacy in developing countries, growing economic feasibility, cheap prices of generic drugs and the ease of ordering medicines from home is going to benefit the growth of the market.

However, the industry has many barriers to overcome. Current reimbursement and regulatory systems, threat of illegal pharmacies and increasing risk of drug abuse. In addition, entry of big e-commerce giants like Amazon and Walmart will also pose a threat to the existing market players.”

Leading companies featured in the report include DocMorris, CVS Caremark, Lloyds Pharma
Walgreens Boots Alliance, Pharmacy2U, Rowlands Pharmacy

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

Read

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

Read

Visiongain Publishes Aptamer Technologies Market Report 2021-2031

Over the last few years, the aptamers has gained widespread attention due to the technological advancements and growth in understanding of the oligonucleotide therapeutics that inhabit the human body.

29 April 2021

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031

Rising prevalence of inflammatory bowel disease including Crohn’s disease and ulcerative colitis; raising awareness for IBD in developing countries; escalating investment in drug R&D by pharmaceutical companies; new product launches worldwide, growing chronic diseases healthcare awareness are some of the major factors that boosting the growth of global IBD drugs market.

29 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever